Oryzon Genomics S.A. (BME: ORY)

Oryzon Genomics Revenue

Oryzon Genomics had revenue of $15.83M USD in the twelve months ending September 30, 2024, down -4.74% year-over-year. In the year 2023, Oryzon Genomics had annual revenue of $14.19M, down -9.60%.

• Revenue (ttm): $15.83M
• Revenue Growth: -4.74%
• P/S Ratio: 6.49
• Revenue / Employee: $344.09K
• Employees: 46
• Market Cap: 93.96M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.19M	-1.51M	-9.60%
Dec 31, 2022	15.70M	5.08M	47.88%
Dec 31, 2021	10.62M	1.09M	11.49%
Dec 31, 2020	9.52M	-756.51K	-7.36%
Dec 31, 2019	10.28M	3.50M	51.57%